Improved Targeting and Safety of Doxorubicin through a Novel Albumin Binding Prodrug Approach

• Yang Liu,
• Sergio Corrales-Guerrero,
• Jimmy C. Kuo,
• Ryan Robb,
• Gregory Nagy,
• Tiantian Cui,
• Robert J. Lee,
• Terence M. Williams

Affiliations

Yang Liu

Division of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, Ohio, United States

Sergio Corrales-Guerrero

Biomedical Sciences Graduate Program, The Ohio State University, Columbus, Ohio, United States

Jimmy C. Kuo

Division of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, Ohio, United States

Ryan Robb

University of North Carolina, Chapel Hill, North Carolina, United States

Gregory Nagy

Biomedical Sciences Graduate Program, The Ohio State University, Columbus, Ohio, United States

Tiantian Cui

Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California, United States

Robert J. Lee

Division of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, Ohio, United States

Terence M. Williams

Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California, United States